CYP1B1 and type 2 diabetes mellitus: In TB-T2DM comorbidity, CYP1B1-induced lipid metabolism dysregulation may impair the ability of macrophages to clear M. tuberculosis, creating a vicious cycle of inflammation and metabolic abnormalities.